American Herbal Products Association (AHPA) > News

Latest News

Subscribe >>

Labeling guidance for fungi products

Guidance becomes effective March 9, 2019

The Board of Trustees of the American Herbal Products Association (AHPA) at its March 9, 2017 meeting authorized issuance of guidance for labeling products that contain fungi ingredients.

AHPA awards Elwood Richard, Scott Bass, Loren Israelsen, Suzanne Shelton and BI Nutraceuticals

AHPA and the entire herbal products industry have greatly benefited from their years of dedication and hard work

The American Herbal Products Association (AHPA) presented its 2017 awards to Elwood Richard, Scott Bass, Loren Israelsen, Suzanne Shelton and BI Nutraceuticals for substantive and positive contributions to the herbal products industry

Trump administration regulatory stop and review in the February 2017 AHPA Report!

February 2017 AHPA Report

AHPA expresses support for synthetic cannabinoids being placed into schedule I

February 2017: AHPA submits comments to DEA

The American Herbal Products Association (AHPA) expressed strong support for the Drug Enforcement Agency (DEA) using its temporary scheduling authority to place synthetic cannabinoids into schedule I in comments submitted to the agency.

AHPA responds to inaccurate media coverage of curcumin mini-perspective

Mini-perspective has been misinterpreted to create inaccurate headlines and articles that misinform the public about turmeric

AHPA Chief Science Officer Maged Sharaf, Ph.D., responded to inaccurate media coverage of a mini-perspecive, "The Essential Medicinal Chemistry of Curcumin,"

Sharaf to discuss AHPA initiatives at 17th annual ICBS in Mississippi

Takeaways from FDA inspections webinar and DEA regulations regarding tableting, encapsulating equipment in the January 2017 AHPA Report!

January 2017 AHPA Report

IADSA update on international supplement regulations

IADSA December 2016 Newsflash

This issue of the IADSA Newsflash includes an update on the Association of Southeast Asian Nations (ASEAN) Agreement on Regulatory Framework for Health Supplements deadline for implementation, which will be pushed back to March 2023.

AHPA submits comments to FDA on revised NDI draft guidance

December 2016: Draft NDI guidance fails to achieve FDA's stated goals and is contrary to intent of the law

In comments submitted to the Food and Drug Administration (FDA), the American Herbal Products Association (AHPA) expressed concern that the latest revision of draft guidance for New Dietary Ingredients (NDIs) is unlikely to achieve FDA's stated goals and is contrary to the intent of the law in numerous areas.

Trump administration and Republic-controlled Congress' impact on the industry in the December AHPA Report!

December 2016

RSS

First Previous 34 35 36 37 38 39 40 41 42 43 Next Last

2022 Annual Fund Sponsors

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.


	Address: 8630 Fenton Street, Suite 918, Silver Spring, MD 20910 Phone: 301.588.1171 Email: ahpa@ahpa.org ©Copyright 2022 AHPA